Charles River Laboratories (CRL) Tops Q1 EPS by 12c, provides guidance
Tweet
Share
E-mail
Get Alerts CRL Hot Sheet
Price: $281.67 +3.02%
Revenue Growth %: -4.3%
Financial Fact:
Net income attributable to common shareowners: 37.74M
Today's EPS Names:
ALZN, ASPU, USAU, More
Revenue Growth %: -4.3%
Financial Fact:
Net income attributable to common shareowners: 37.74M
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Charles River Laboratories (NYSE: CRL) reported Q1 EPS of $2.06, $0.12 better than the analyst estimate of $1.94. Revenue for the quarter came in at $995.8 million versus the consensus estimate of $978.34 million.
GUIDANCE:
Charles River Laboratories sees FY 2026 EPS of $10.80-$11.30, versus the consensus of $11.07.
For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nucor projects Q3 2026 earnings above prior year, below estimates
- Treace reports 5-year Lapiplasty study data at AOFAS meeting
- Alphabet (GOOGL) PT Raised to $485 at Tigress Financial Partners
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
